Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 1: Fit-for-Purpose Approach to Classification of Clinical Immunohistochemistry Biomarkers.
Cheung CC, D'Arrigo C, Dietel M, Francis GD, Gilks CB, Hall JA, Hornick JL, Ibrahim M, Marchetti A, Miller K, van Krieken JH, Nielsen S, Swanson PE, Taylor CR, Vyberg M, Zhou X, Torlakovic EE; From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path). Cheung CC, et al. Among authors: vyberg m. Appl Immunohistochem Mol Morphol. 2017 Jan;25(1):4-11. doi: 10.1097/PAI.0000000000000451. Appl Immunohistochem Mol Morphol. 2017. PMID: 27922482
Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.
Torlakovic EE, Francis G, Garratt J, Gilks B, Hyjek E, Ibrahim M, Miller R, Nielsen S, Petcu EB, Swanson PE, Taylor CR, Vyberg M; International Ad Hoc Expert Panel. Torlakovic EE, et al. Among authors: vyberg m. Appl Immunohistochem Mol Morphol. 2014 Apr;22(4):241-52. doi: 10.1097/PAI.0000000000000069. Appl Immunohistochem Mol Morphol. 2014. PMID: 24714041 Free PMC article.
Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee.
Torlakovic EE, Nielsen S, Francis G, Garratt J, Gilks B, Goldsmith JD, Hornick JL, Hyjek E, Ibrahim M, Miller K, Petcu E, Swanson PE, Zhou X, Taylor CR, Vyberg M. Torlakovic EE, et al. Among authors: vyberg m. Appl Immunohistochem Mol Morphol. 2015 Jan;23(1):1-18. doi: 10.1097/PAI.0000000000000163. Appl Immunohistochem Mol Morphol. 2015. PMID: 25474126 Review.
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine: Part 4: Tissue Tools for Quality Assurance in Immunohistochemistry.
Cheung CC, D'Arrigo C, Dietel M, Francis GD, Fulton R, Gilks CB, Hall JA, Hornick JL, Ibrahim M, Marchetti A, Miller K, van Krieken JH, Nielsen S, Swanson PE, Taylor CR, Vyberg M, Zhou X, Torlakovic EE; From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path). Cheung CC, et al. Among authors: vyberg m. Appl Immunohistochem Mol Morphol. 2017 Apr;25(4):227-230. doi: 10.1097/PAI.0000000000000469. Appl Immunohistochem Mol Morphol. 2017. PMID: 27941560
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine - Part 2: Immunohistochemistry Test Performance Characteristics.
Torlakovic EE, Cheung CC, D'Arrigo C, Dietel M, Francis GD, Gilks CB, Hall JA, Hornick JL, Ibrahim M, Marchetti A, Miller K, van Krieken JH, Nielsen S, Swanson PE, Vyberg M, Zhou X, Taylor CR; From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path). Torlakovic EE, et al. Among authors: vyberg m. Appl Immunohistochem Mol Morphol. 2017 Feb;25(2):79-85. doi: 10.1097/PAI.0000000000000444. Appl Immunohistochem Mol Morphol. 2017. PMID: 28182587 Review.
Evolution of Quality Assurance for Clinical Immunohistochemistry in the Era of Precision Medicine. Part 3: Technical Validation of Immunohistochemistry (IHC) Assays in Clinical IHC Laboratories.
Torlakovic EE, Cheung CC, D'Arrigo C, Dietel M, Francis GD, Gilks CB, Hall JA, Hornick JL, Ibrahim M, Marchetti A, Miller K, van Krieken JH, Nielsen S, Swanson PE, Vyberg M, Zhou X, Taylor CR; From the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and International Quality Network for Pathology (IQN Path). Torlakovic EE, et al. Among authors: vyberg m. Appl Immunohistochem Mol Morphol. 2017 Mar;25(3):151-159. doi: 10.1097/PAI.0000000000000470. Appl Immunohistochem Mol Morphol. 2017. PMID: 28187030
Thyroid transcription factor-1 in primary CNS tumors.
Kristensen MH, Nielsen S, Vyberg M. Kristensen MH, et al. Among authors: vyberg m. Appl Immunohistochem Mol Morphol. 2011 Oct;19(5):437-43. doi: 10.1097/PAI.0b013e31820e6baf. Appl Immunohistochem Mol Morphol. 2011. PMID: 21325940
137 results